I don't think even the most bullish on this board would (or SHOULD) be offended by anyone who points out that CYDY's ability to use leronlimab to potentially save lives, even with FDA approval, is dependent upon CYDY's ability to supply leronlimab in needed quantities!

I think you are correct to point out that manufacturing capacity is important. I also think that is why getting the BLA in is important. IMO, it would be easier for FDA to grant emergency approval if the CMC portion of the BLA was on file.